Catalpol Inhibits Tregs-to-Th17 Cell Transdifferentiation by Up-Regulating Let-7g-5p to Reduce STAT3 Protein Levels
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease, and Th17 cells are key factors in the pathogenesis of human inflammatory conditions, such as RA. Catalpol (CAT), a component in Rehmanniae Radix (RR), has been found to regulate human immunity. However, the effects of CAT on Th17 cell differentiation and improvement of RA are not clear. Materials and Methods: Collagen-induced arthritis (CIA) mice were constructed to detect the effects of CAT on arthritis and Th17 cells. The effect of CAT on Th17 differentiation was evaluated with let-7g-5p transfection experiments. Flow cytometry was used to detect the proportion of Th17 cells after CAT treatment. Levels of interleukin-17 and RORγt were assessed by qRT-PCR and enzyme-linked immunosorbent assay. The expression of signal transducer and activator of transcription 3 (STAT3) was determined by qRT-PCR and Western blot. Results: We found that the proportion of Th17 cells was negatively associated with let-7g-5p expression in CIA mice. In in vitro experiments, CAT suppressed traditional differentiation of Th17 cells. Simultaneously, CAT significantly decreased Tregs-to-Th17 cells transdifferentiation. Our results demonstrated that CAT inhibited Tregs-to-Th17 cells transdifferentiation by up-regulating let-7g-5p and that the suppressive effect of CAT on traditional differentiation of Th17 cells is not related with let-7-5p. Conclusion: Our data indicate that CAT may be a potential modulator of Tregs-to-Th17 cells transdifferentiation by up-regulating let-7g-5p to reduce the expression of STAT3. These results provide new directions for research into RA treatment.
Abstract
Purpose: Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease, and Th17 cells are key factors in the pathogenesis of human inflammatory conditions, such as RA. Catalpol (CAT), a component in Rehmanniae Radix (RR), has been found to regulate human immunity. However, the effects of CAT on Th17 cell differentiation and improvement of RA are not clear. Materials and Methods: Collagen-induced arthritis (CIA) mice were constructed to detect the effects of CAT on arthritis and Th17 cells. The effect of CAT on Th17 differentiation was evaluated with let-7g-5p transfection experiments. Flow cytometry was used to detect the proportion of Th17 cells after CAT treatment. Levels of interleukin-17 and RORγt were assessed by qRT-PCR and enzyme-linked immunosorbent assay. The expression of signal transducer and activator of transcription 3 (STAT3) was determined by qRT-PCR and Western blot. Results: We found that the proportion of Th17 cells was negatively associated with let-7g-5p expression in CIA mice. In in vitro experiments, CAT suppressed traditional differentiation of Th17 cells. Simultaneously, CAT significantly decreased Tregs-to-Th17 cells transdifferentiation. Our results demonstrated that CAT inhibited Tregs-to-Th17 cells transdifferentiation by up-regulating let-7g-5p and that the suppressive effect of CAT on traditional differentiation of Th17 cells is not related with let-7-5p. Conclusion: Our data indicate that CAT may be a potential modulator of Tregs-to-Th17 cells transdifferentiation by up-regulating let-7g-5p to reduce the expression of STAT3. These results provide new directions for research into RA treatment.
참고문헌 (36)
- Köhler BM, "Current therapeutic options in the treatment of rheumatoid arthritis", J Clin Med, 8, pp.938~ (2019)
- Smolen JS, "Rheumatoid arthritis", Lancet, 388, pp.2023~2038 (2016)
- Kondo Y, "Transcriptional regulation of CD4+ T cell differentiation in experimentally induced arthritis and rheumatoid arthritis", Arthritis Rheumatol, 70, pp.653~661 (2018)
- Chen Q, "Catalpol inhibits macrophage polarization and prevents postmenopausal atherosclerosis through regulating estrogen receptor alpha", Front Pharmacol, 12, pp.655081~ (2021)
- Zhao L, "Catalpol protects against high glucose-induced bone loss by regulating osteoblast function", Front Pharmacol, 12, pp.626621~ (2021)
- Zhao L, "Catalpol inhibits cell proliferation, invasion and migration through regulating miR-22-3p", MTA3 signalling in hepatocellular carcinoma, 2019, pp.109, 51~60
- Bhattamisra SK, "Multiple biological effects of an iridoid glucoside, catalpol, and its underlying molecular mechanisms", Biomolecules, 10, pp.32~ (2019)
- Yang P, "Th17 cell pathogenicity and plasticity in rheumatoid arthritis", J Leukoc Biol, 106, pp.1233~1240 (2019)
- Park JS, "Retinoic acid receptor-related receptor alpha ameliorates autoimmune arthritis via inhibiting of Th17 cells and osteoclastogenesis", Front Immunol, 10, pp.2270~ (2019)
- Yasuda K, "The pathogenicity of Th17 cells in autoimmune diseases", Semin Immunopathol, 41, pp.283~297 (2019)
- Korn T, "IL-17 and Th17 cells", Annu Rev Immunol, 27, pp.485~517 (2009)
- Verstappen GM, "Th17 cells in primary Sjögren’s syndrome : pathogenicity and plasticity", J Autoimmun, 87, pp.16~25 (2018)
- Liu ZZ, "The transdifferentiation of regulatory T and Th17 cells in autoimmune", inflammatory diseases and its potential implications in pregnancy complications, 2017, pp.78, e12657~
- Andersson KM, "Pathogenic transdifferentiation of Th17 cells contribute to perpetuation of rheumatoid arthritis during anti-TNF treatment", Mol Med, 21, pp.536~543 (2015)
- Garzon R, "Targeting microRNAs in cancer : rationale, strategies and challenges", Nat Rev Drug Discov, 9, pp.775~789 (2010)
- Cunningham CC, "Serum miRNA signature in rheumatoid arthritis and"at-risk individuals"", Front Immunol, 12, pp.633201~ (2021)
- Honardoost MA, "Integrative computational mRNA-miRNA interaction analyses of the autoimmune-deregulated miRNAs and well-known Th17differentiation regulators : an attempt to discover new potential miRNAs involved in Th17 differentiation", Gene, 572, pp.153~162 (2015)
- Hu R, "MicroRNA-155 confers encephalogenic potential to Th17cells by promoting effector gene expression", J Immunol, 190, pp.5972~5980 (2013)
- Lee H, "Biogenesis and regulation of the let7 miRNAs and their functional implications", Protein Cell, 7, pp.100~113 (2016)
- Yang P, "MicroRNA let-7g-5p alleviates murine collagen-induced arthritis by inhibiting Th17 cell differentiation", Biochem Pharmacol, 174, pp.113822~ (2020)
- Ramos MI, "Absence of Fms-like tyrosine kinase 3 ligand(Flt3L)signalling protects against collagen-induced arthritis", Ann Rheum Dis, 74, pp.211~219 (2013)
- Kotake S, "IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis", J Clin Invest, 103, pp.1345~1352 (1999)
- Lubberts E, "Th17 cytokines and arthritis", Semin Immunopathol, 32, pp.43~53 (2010)
- Lv H, "Innovated formulation of TCM pangolin scales to develop a nova therapy of rheumatoid arthritis", Biomed Pharmacother, 126, pp.109872~ (2020)
- Xing Q, "Efficacy and safety of integrated traditional Chinese medicine and Western medicine on the treatment of rheumatoid arthritis : a meta-analysis", Evid Based Complement Alternat Med, 2020, pp.4348709~ (2020)
- Lü S, "The treatment of rheumatoid arthritis using Chinese medicinal plants : from pharmacology to potential molecular mechanisms", J Ethnopharmacol, 176, pp.177~206 (2015)
- Chen YJ, "An herbal formula inhibits STAT3 signaling and attenuates bone erosion in collagen-induced arthritis rats", Phytomedicine, 76, pp.153254~ (2020)
- Oike T, "Stat3 as a potential therapeutic target for rheumatoid arthritis", Sci Rep, 7, pp.10965~ (2017)
- Liu J, "MicroRNA-29a inhibits proliferation and induces apoptosis in rheumatoid arthritis fibroblast-like synoviocytes by repressing STAT3", Biomed Pharmacother, 96, pp.173~181 (2017)
- Isomäki P, "The activity of JAK-STAT pathways in rheumatoid arthritis: constitutive activation of STAT3 correlates with interleukin 6 levels", Rheumatology (Oxford), 54, pp.1103~1113 (2015)
- Purvis HA, "A negative feedback loop mediated by STAT3 limits human Th17 responses", J Immunol, 193, pp.1142~1150 (2014)
- Zhao M, "IL-6", STAT3pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation, 2018, pp.9, 583~
- Zhang M, "A STAT3palmitoylation cycle promotes TH17 differentiation and colitis", Nature, 586, pp.434~439 (2020)
- Shui X, "Knockdown of lncRNA NEAT1 inhibits Th17", CD4+ T cell differentiation through reducing the STAT3 protein level, 2019, pp.234, 22477~22484
- Chang H, "PPARα suppresses Th17 cell differentiation through IL-6", STAT3, Exp Cell Res, pp.2019, 375[DOI]
- Liu X, "The role of STAT3and AhR in the differentiation of CD4+ T cells into Th17 and Treg cells", Medicine(Baltimore), 96, pp.e6615~ (2017)